/Investor DB

CPP Investments — 2020 Investments

4 investments dated 2020 · listed companies and verified rows first · show all

Grailgrail.comin𝕏NASDAQ: GRALMay 2020

GRAIL develops the Galleri blood test for multi-cancer early detection using next-generation sequencing and machine learning to screen for multiple deadly cancer types before symptoms appear.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesMenlo Park, US

Jeffrey T. Huber(Director)Joshua Ofman, MD, MSHS(Chief Executive Officer)inAaron Freidin(Executive Officer)inRobert Ragusa(Executive Officer, Director)Jennifer Cook(Executive Officer, Director)inRichard Klausner(Director)

Co-investorsAmino CapitalARCH Venture PartnersBezos ExpeditionsBluebird VenturesDecheng CapitalDentsu Ventures+13 more

Galileo Global Educationggeedu.cominJul 2020

Galileo Global Education is a provider of independent higher education, offering programs in business and management, arts and creative fields, digital and tech, and health.

EdTech

Co-investorsMontaguBpifranceTéthys Invest

Insitroinsitro.comin𝕏Mar 2020

insitro is a drug discovery and development company that uses machine learning and cellular data to identify therapeutic insights and accelerate the creation of new medicines.

AI & Machine LearningBiotechSouth San Francisco, US

Daphne Koller(Founder)inDuane Valz(General Counsel)inMary Rozenman(Chief Financial Officer)in

BoardRobert Nelsen(Director)Vijay Pande(Director)in

Co-investorsAndreessen HorowitzARCH Venture PartnersDeviation CapitalForesite CapitalGV (Google Ventures)HOF Capital+9 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

NexGrid Technologies

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.